Diabetes Type 2, Smoking Cessation
Conditions
Keywords
financial incentives, contingency management
Brief summary
The purpose of this study is to evaluate the feasibility of contingency management on improving smoking cessation among individuals with type 2 diabetes.
Detailed description
Type 2 diabetes (T2DM) and cigarette smoking are major causes of morbidity and mortality in US, and research indicates there is a complex relationship between these two risk factors. Smoking cessation is recommended as a standard treatment of diabetes by the American Diabetes Association; however, patients with T2DM and their providers are often inundated with other challenging lifestyle changes and disease management. Due to the complex relationship between diabetes and smoking and the large number of competing lifestyle changes recommended at diagnosis, smokers with T2DM may benefit from a contingency management (CM) program that incentivizes cessation. Providing patients tangible rewards to reinforce positive behaviors such as smoking abstinence has been proven effective in substance abuse programs, smoking cessation among pregnant women unwilling or unable to quit, and other population subgroups. In this CRUK2 study the investigators aim to test and further explore the potential effectiveness of financial incentives contingent upon proof of quitting smoking. The investigators will gather diabetes-related contextual factors associated with participation in the program and smoking cessation.
Interventions
BEHAVIORALContingency Management
Escalating financial incentives contingent upon biochemical evidence of abstinence
BEHAVIORALUsual Care smoking cessation
Usual care smoking cessation support
Sponsors
University of Oklahoma
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
Yes
Inclusion criteria
* Diagnosed with type 2 diabetes * earn a score \> 4 on REALM indicating \> 6th grade English literacy level * willing to quit smoking 7 days from their first visit * have an expired CO level \>8 ppm suggestive of current smoking at baseline * currently smoking \> 5 cigarettes per day * willing and able to attend 6 study visits
Exclusion criteria
* unable to demonstrate use of or unwilling to use the remote CO monitor and phone app
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Number of participants completing 6 study visits | 5 weeks | Feasibility outcome: completion of 6 study visits |
| Number of participants with >80% completion of daily ecological momentary assessments (EMA) completed | 4 weeks | Feasibility outcome: completion of EMA portion of study |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Number of participants with biochemically verified abstinence at 4 weeks post quit | 5 weeks | Carbon Monoxide (CO) ≤ 6 ppm on exit date; self-reported 7-day point prevalence abstinence |
Countries
United States
Outcome results
None listed